Green Sands Equity

Paradromics, Inc. is focused on developing brain-machine interfaces that facilitate data transmission between the brain and machines, primarily targeting the treatment of neurodegenerative diseases. The company creates implantable systems capable of decoding complex neural recordings into data streams, which can be utilized by various neural prostheses. Its technology emphasizes high-volume, bidirectional data streaming, allowing patients with neurological disorders to reconnect with their environment and compensate for lost biological connectivity. Founded in 2015 and headquartered in Austin, Texas, Paradromics also offers applications to support its product suite, aiming to enhance the quality of life for individuals with disabilities.

Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

ArsenalBio is a programmable cell therapy company focused on creating effective and accessible immune cell therapies, particularly for cancer patients. Established in 2019, the company integrates advanced technologies, including CRISPR-based genome engineering, synthetic biology, and machine learning, to revolutionize the discovery and development of immune cell therapies. ArsenalBio employs a comprehensive research and development approach to produce multifunctional T-cell therapies, utilizing the precise insertion of large synthetic DNA sequences. The company's mission is to enhance the efficacy and safety of immune cell therapies while reducing costs for providers and expanding access for patients. Through its innovative framework, ArsenalBio aims to significantly improve treatment outcomes for a broader patient population.

Stepful is a training platform designed to assist individuals without college degrees in entering the healthcare job market. The company offers a comprehensive curriculum that includes online instructor-led classes, electronic textbooks, practice quizzes, and flashcards. Additionally, Stepful provides in-person clinical sessions to develop hands-on skills, particularly in bloodwork. To further support its users, the platform also includes job placement assistance, helping graduates secure entry-level positions in the healthcare industry and facilitating opportunities for career advancement. By focusing on high school graduates, Stepful aims to fill vacancies in the healthcare sector quickly while reducing hiring costs for employers.

Good Chemistry Company focuses on enhancing health, cleanliness, and sustainability through advanced material design. It has developed a proprietary cloud-based computational chemistry platform called QEMIST Cloud. This platform empowers computational chemistry developers to create chemical simulation applications and workflows by utilizing cutting-edge algorithms in quantum chemistry, machine learning, and quantum computing. By predicting chemical properties with remarkable speed and scale, Good Chemistry contributes significantly to the field of computational chemistry, facilitating innovation and efficiency in material design.

Colossal Biosciences is an innovative firm in the field of bioscience and genetic engineering, focused on advancing genomics technology. The company is dedicated to developing transformative solutions for the restoration of extinct species, protection of critically endangered species, and the repopulation of essential ecosystems. Utilizing CRISPR technology, Colossal aims to facilitate species de-extinction, starting with the woolly mammoth, thereby enabling environmental organizations to rehabilitate ecosystems and promote biodiversity. Through its efforts, Colossal seeks to address ecological challenges while also considering the economic and biological needs of humanity.

Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technology to enable a simplified experience, and by partnering with top providers for better health outcomes.

USA Rare Earth LLC, founded in 2019 and based in New York, focuses on the exploration and processing of critical minerals, including rare earth elements, lithium, uranium, and beryllium. The company's primary project, located in Hudspeth County, Texas, is the Round Top Deposit, which is noted for its extensive range of heavy rare earth elements and other high-value tech minerals. Round Top is recognized as one of the lowest-cost rare earth projects globally and hosts 13 of the 35 minerals classified as "critical" by the Department of the Interior, essential for national defense and industrial applications. USA Rare Earth aims to establish itself as a key supplier of heavy rare earth materials for the U.S. Department of Defense, addressing the country’s reliance on Chinese imports, which currently account for 80% of U.S. rare earth material imports. The company anticipates initiating full production at the Round Top mine as early as 2022, positioning itself as a pivotal player in the U.S. commercial and defense sectors.

Commure, Inc. is a developer of an open platform designed to facilitate the creation and deployment of next-generation healthcare applications. The platform enables healthcare software developers to build FHIR-native applications, providing a secure, reliable, and interoperable foundation. Key features include an FHIR API server, security framework, event service bus, EHR integration, API gateway, and flexible data storage options. This comprehensive infrastructure supports healthcare professionals, including doctors and nurses, in addressing daily challenges and enhancing patient care through innovative solutions. Founded in 2017, Commure is headquartered in San Francisco, California, with additional offices in Boston, Massachusetts; Montreal, Canada; and Bogota, Colombia.

AST & Science, LLC, based in Midland, Texas, develops ultra-small satellites and is creating a global broadband cellular network in space, known as SpaceMobile. This innovative network aims to provide 4G and 5G connectivity directly to standard mobile devices without requiring additional satellite hardware. Founded in 2017, AST & Science seeks to address the connectivity challenges faced by billions of mobile subscribers worldwide, particularly those in underserved areas. The company's extensive intellectual property and patent portfolio support its mission to bridge the digital divide and bring reliable broadband access to the unconnected population globally.

ReViral Ltd is a biotechnology company based in Stevenage, United Kingdom, that specializes in the discovery and development of antiviral drugs targeting the respiratory syncytial virus (RSV). Founded in 2011, ReViral focuses on creating novel first-in-class compounds, including a highly potent fusion inhibitor designed to treat severe RSV infections, particularly in vulnerable populations such as neonates. The company's innovative approach aims to expand the antiviral market by providing effective treatment options for patients affected by RSV, a virus known for causing significant respiratory illness. Through its research and development efforts, ReViral seeks to address unmet medical needs in the realm of viral infections.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders associated with neuronal imbalance. The company's lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator currently undergoing Phase IIa clinical trials for major depressive disorder and perimenopausal depression, and PRAX-944, a selective small molecule inhibitor of T-type calcium channels in Phase IIa trials for essential tremor. Additionally, Praxis is advancing PRAX-562, a persistent sodium current blocker in Phase I trials for severe pediatric epilepsy and adult cephalgia, as well as PRAX-222, an antisense oligonucleotide targeting SCN2A epilepsy, and a program for KCNT1 GOF epilepsy. The company engages in collaborations and licensing agreements with various partners, including RogCon Inc., Purdue Neuroscience Company, and Ionis Pharmaceuticals. Founded in 2015, Praxis Precision Medicines is headquartered in Cambridge, Massachusetts.

Encoded Therapeutics, Inc. is a biotechnology company focused on developing precision gene therapies for severe genetic disorders. The company's innovative platform identifies sequences within the human genome that regulate gene expression through advanced screening and computational methods. Its therapy pipeline targets a variety of genetic and acquired disorders across multiple disease pathways, including neurocircuitry, liver and metabolic disorders, neurodegeneration, and cardiovascular diseases. Founded in 2014 and headquartered in South San Francisco, California, Encoded Therapeutics aims to enhance treatment options available to medical practitioners, ultimately improving patient outcomes and quality of life.

1QB Information Technologies is a quantum computing software company. 1QBit solves computational challenges by recasting problems to harness the power of quantum computing.

Lyft is an on-demand transportation service that connects riders with drivers through a mobile application, allowing users to request rides and make payments seamlessly. Founded in June 2012 in San Francisco, Lyft has become the second-largest ridesharing provider in the U.S. and Canada, serving approximately 95 percent of the U.S. population. The platform offers various ride options, including traditional private rides, shared rides, and luxury vehicles. In addition to standard ride-sharing services, Lyft has expanded into the bike and scooter-sharing market, promoting multimodal transportation solutions. The service is particularly popular among college, university, and corporate communities, and it allows riders to schedule rides up to seven days in advance.